Effects of ospemifene on bone in postmenopausal women

Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness

(2019) David F. Archer et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Effects of ospemifene on bone parameters including clinical biomarkers in postmenopausal women

(2016) Ginger D. Constantine et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

The epidemiology of mortality after fracture in England: variation by age, sex, time, geographic location, and ethnicity

(2016) C. Klop et al.   OSTEOPOROSIS INTERNATIONAL

A 7-year randomized, placebo-controlled trial assessing the long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis

(2015) Santiago Palacios et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density at the Femoral Neck or Lumbar Spine

(2014) Nicole C Wright et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Tissue selectivity of ospemifene: Pharmacologic profile and clinical implications

(2013) Lauri Kangas et al.   STEROIDS

Osteoporosis in the European Union: medical management, epidemiology and economic burden

(2013) E. Hernlund et al.   Archives of Osteoporosis

Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial*

(2008) Stuart L Silverman et al.   JOURNAL OF BONE AND MINERAL RESEARCH